CWM
REFR icon

Chemistry Wealth Management’s Research Frontiers REFR Stock Holding History

Chemistry Wealth Management’s Portfolio REFR Stock Details REFR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-16,000
Closed -$28K – 178
2021
Q4 		$28K Buy
+16,000
New +$34.3K 0.02% 85

Other funds holding REFR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SRC
Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MCC
Money Concepts Capital Palm Beach Gardens, Florida $1.81B AUM 21.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
KWM
Kingsview Wealth Management Grants Pass, Oregon $7.33B AUM 16.07% 1-Year Est. Return

Chemistry Wealth Management's REFR Position: Q1 2022 in Review

Chemistry Wealth Management sold out of Research Frontiers (REFR) in Q1 2022, closing a stake of 16,000 shares — an estimated $28K sold.

Chemistry Wealth Management first reported a position in REFR in Q4 2021 and held it in 1 quarter. The position peaked at $28K in Q4 2021. 31 funds tracked by Wall St. Rank hold REFR as of Q1 2022.

  • Chemistry Wealth Management reported no remaining Research Frontiers position as of Q1 2022 after selling out during the quarter.
  • Chemistry Wealth Management sold 16,000 Research Frontiers shares in Q1 2022, an estimated $28K.
  • Chemistry Wealth Management first reported a position in Research Frontiers in Q4 2021 and held it in 1 quarter.
  • Chemistry Wealth Management's Research Frontiers position peaked at $28K in Q4 2021.
  • 31 funds tracked by Wall St. Rank held Research Frontiers as of Q1 2022.

Based on Chemistry Wealth Management's 13F filing for Q1 2022, filed 5 May 2022.